A new selective aldosterone antagonist. Inspra's role in hypertension and post-MI heart failure.
Ostrenga
Andrew
A
University of Mississippi School of Pharmacy, Jackson, Miss., USA.
Pitcock
James
J
Pitcock
Margaret
M
D001145:Arrhythmias, Cardiac / Q000139:chemically induced; D004347:Drug Interactions; D000077545:Eplerenone; D019317:Evidence-Based Medicine; D006333:Heart Failure / Q000188:drug therapy* / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000453:epidemiology; D009203:Myocardial Infarction / Q000150:complications* / Q000453:epidemiology; D018579:Patient Selection; D011788:Quality of Life; D012307:Risk Factors; D013148:Spironolactone / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use*; D014481:United States / Q000453:epidemiology
D013148:Spironolactone; D000077545:Eplerenone